Insider trade

CEO exercised or converted 275 TMO derivative securities

Traded Aug 24, 2026 · Filed Aug 26, 2026

Thermo Fisher ScientificTMO

275
Derivative units

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 24, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 26, 2026

CEOOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001216055-26-000012

Filed / recorded

Aug 26, 2026, 8:01 PM UTC

Added to OQRO

Oct 2, 2026, 12:28 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

THERMO FISHER SCIENTIFIC INC.

Issuer CIK

97745

Ticker

TMO

Reporting person

Marc N Casper

Relationship

Director, Officer

Officer title

Chairman & CEO

Security

Stock Option (Right to Buy)

Table

Derivative (Table II)

Transaction date

Aug 24, 2026

Transaction code

M

Shares / units

275

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

0

Ownership form

Direct

Amendment

No

Footnotes from the filing

The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024.

Around the same time

5w ago

724.77Shares · @ $622.18

Routine share withholding; mechanical by default.

Why it stands out Official record

5w ago

531.85Shares · @ $622.18

Routine share withholding; mechanical by default.

Why it stands out Official record

5w ago

37.23Shares · @ $622.18

Routine share withholding; mechanical by default.

Why it stands out Official record